3 , llb-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
Details for Australian Patent Application No. 2006277836 (hide)
International Classifications
Event Publications
3 April 2008 PCT application entered the National Phase
PCT publication WO2007/017643 Priority application(s): WO2007/017643
1 October 2009 Assignment before Grant
Cambridge Laboratories (Ireland) Limited The application has been assigned to Biovail Laboratories International (Barbados) SRL 2007
10 November 2011 Application Accepted
Published as AU-B-2006277836
8 December 2011 Corrigenda
Applications Accepted - Name Index Under the name Biovail Laboratories International (Barbados) SRL, Application No. 2006277836, under INID (72) correct the co -inventor to Yarrow, Jean Elisabeth
15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser